PIN40 Cost-Effectiveness of Boceprevir-Based Treatment of Chronic Genotype 1 Hepatitis C Virus (HCV) Infection From the Perspective of the German Statutory Health Insurance (SHI)
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1107
https://www.valueinhealthjournal.com/article/S1098-3015(12)02820-3/fulltext
Title :
PIN40 Cost-Effectiveness of Boceprevir-Based Treatment of Chronic Genotype 1 Hepatitis C Virus (HCV) Infection From the Perspective of the German Statutory Health Insurance (SHI)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02820-3&doi=10.1016/j.jval.2012.08.1107
First page :
A392
Section Title :
Infection
Open access? :
No
Section Order :
608